Trends in comorbidity in patients hospitalised for cardiovascular disease

Josefien Buddeke1, Michiel L Bots2, Ineke van Dis3

  • 1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands; Dutch Heart Foundation, The Hague, The Netherlands.

Insights

Comorbidities are common in cardiovascular disease (CVD) patients, especially older adults. While cardiovascular comorbidities decreased, cancer prevalence increased significantly in men and women between 2000-2010.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Investigating temporal trends in cardiovascular and non-cardiovascular comorbidities among hospitalized cardiovascular disease (CVD) patients.
  • Understanding the evolving landscape of patient health beyond primary cardiovascular conditions.

Purpose of the Study:

  • To determine trends in cardiovascular and non-cardiovascular comorbidity in patients hospitalized for CVD.
  • To analyze these trends across different age groups, sexes, and specific CVD types (CHD, CVA, HF, PAD).

Main Methods:

  • Utilized the Dutch nationwide hospital register for CVD hospitalizations from 2000-2010.
  • Defined comorbidity based on previous hospital admissions for specific conditions within five years prior to index CVD hospitalization.
  • Analyzed trends stratified by age, sex, and CVD type: coronary heart disease (CHD), cerebrovascular disease (CVA), heart failure (HF), and peripheral arterial disease (PAD).

Main Results:

  • Identified 2,397,773 CVD admissions; 38% had comorbidity, highest in HF (54%) and PAD (46%).
  • Overall comorbidity increased by 1.1% from 2000-2010, most notably in patients aged ≥75 years (+3.0%).
  • Cardiovascular comorbidity prevalence decreased (men -5%, women -2%), while non-cardiovascular comorbidity increased (men +4%, women -1%), with cancer showing a significant rise in both sexes (+5% men, +4% women).

Conclusions:

  • Comorbid conditions are highly prevalent in hospitalized CVD patients, particularly those with heart failure (HF) and peripheral arterial disease (PAD).
  • Comorbidity prevalence increased over time, especially in older patients.
  • While cardiovascular comorbidities decreased in prevalence, cancer comorbidity significantly increased, highlighting a shift in the comorbidity profile of CVD patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
535
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
716
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.3K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
474
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
337
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
343